Published online December 31, 2007
PEDIATRICS Vol. 121 No. 1 January 2008, pp. 142-147 (doi:10.1542/peds.2007-0925)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lemmers, P. M. A.
Right arrow Articles by van Bel, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lemmers, P. M. A.
Right arrow Articles by van Bel, F.
Related Collections
Right arrow Premature & Newborn
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Impact of Patent Ductus Arteriosus and Subsequent Therapy With Indomethacin on Cerebral Oxygenation in Preterm Infants

Petra M. A. Lemmers, MD, Mona C. Toet, MD, PhD and Frank van Bel, MD, PhD

Department of Neonatology, University Medical Center/Wilhelmina Children's Hospital, Utrecht, Netherlands

OBJECTIVES. A hemodynamically important patent ductus arteriosus is a common problem in the first week of life in the preterm infant. Although patent ductus arteriosus induces alterations in organ perfusion, scarce information is available of the impact of patent ductus arteriosus and its subsequent treatment on the oxygen supply and oxygen extraction of the brain. We investigated the impact of patent ductus arteriosus and its treatment with indomethacin on regional cerebral oxygen saturation and fractional tissue oxygen extraction by using near-infrared spectroscopy.

PATIENTS AND METHODS. Twenty infants with patent ductus arteriosus (gestational age: <32 weeks), subsequently treated with indomethacin, were monitored for mean arterial blood pressure, arterial oxygen saturation, near-infrared spectroscopy–determined regional cerebral oxygen saturation, and fractional tissue oxygen extraction ([arterial oxygen saturation – regional cerebral oxygen saturation]/arterial oxygen saturation). Ten-minute periods were selected and averaged during patent ductus arteriosus, at 10, 20, 30, 60, and 120 minutes, and at 6,12, 24, and 36 hours after starting indomethacin treatment (to ductal closure) for mean arterial blood pressure, arterial oxygen saturation, regional cerebral oxygen saturation, and fractional tissue oxygen extraction. The patients with patent ductus arteriosus were matched for gestational age, birth weight, postnatal age, and severity of respiratory distress syndrome with infants without patent ductus arteriosus, who served as control subjects.

RESULTS. Mean arterial blood pressure and regional cerebral oxygen saturation were significantly lower and fractional tissue oxygen extraction significantly higher compared with the control infants during patent ductus arteriosus (mean arterial blood pressure: 33 ± 5 vs 38 ± 6 mmHg; regional cerebral oxygen saturation: 62% ± 9% vs 72% ± 10%; fractional tissue oxygen extraction: 0.34 ± 0.1 vs 0.25 ± 0.1, respectively). Regional cerebral oxygen saturation and fractional tissue oxygen extraction were lower and higher, respectively, up to 24 hours after the start of indomethacin but normalized to control values afterward. Indomethacin had no additional negative effect on cerebral oxygenation.

CONCLUSIONS. A hemodynamically significant patent ductus arteriosus has a negative effect on cerebral oxygenation in the premature infant. Subsequent and adequate treatment of a patent ductus arteriosus may prevent diminished cerebral perfusion and subsequent decreased oxygen delivery, which reduces the change of damage to the vulnerable immature brain.

Key Words: preterm infant • near-infrared spectroscopy • cerebral oxygenation • patent ductus arteriosus • indomethacin

Abbreviations: PDA—persistent ductus arteriosus • NIRS—near-infrared spectroscopy • GA—gestational age • SaO2—arterial oxygen saturation • rScO2—regional cerebral oxygen saturation • FTOE—fractional tissue oxygen extraction • MABP—mean arterial blood pressure

Accepted Jun 27, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 PediatricsHome page
E. A. Verhagen, P. Keating, H. J. ter Horst, A. Martijn, and A. F. Bos
Cerebral Oxygen Saturation and Extraction in Preterm Infants With Transient Periventricular Echodensities
Pediatrics, July 1, 2009; 124(1): 294 - 301.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. M. Dagle, N. T. Lepp, M. E. Cooper, K. L. Schaa, K. J.P. Kelsey, K. L. Orr, D. Caprau, C. R. Zimmerman, K. M. Steffen, K. J. Johnson, et al.
Determination of Genetic Predisposition to Patent Ductus Arteriosus in Preterm Infants
Pediatrics, April 1, 2009; 123(4): 1116 - 1123.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
S. Noori, M. McCoy, P. Friedlich, B. Bright, V. Gottipati, I. Seri, and K. Sekar
Failure of Ductus Arteriosus Closure Is Associated With Increased Mortality in Preterm Infants
Pediatrics, January 1, 2009; 123(1): e138 - e144.
[Abstract] [Full Text] [PDF]